Markets › India › NSE › SYNCOMF

Syncom Formulation (India) Ltd

NSE:SYNCOMFHealthcare

₹21.41−2.46%At closeAt close · Mon 19 Oct · ≈ AED 0.8261 · Market cap $216.47M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	30.2%	32.6%	36.8%	21.2%	33.9%	26.8%	—	—
Operating margin	12.0%	6.8%	6.8%	8.1%	10.5%	14.5%	14.5%	+0.0 pts
Net margin	12.2%	9.1%	8.9%	9.6%	10.6%	15.6%	15.6%	+0.0 pts
EBITDA margin	18.8%	14.7%	15.2%	16.3%	15.3%	22.2%	—	—
Return on equity	15.6%	8.9%	7.8%	8.8%	14.4%	18.4%	18.4%	+0.0 pts
Return on assets	10.0%	6.4%	5.3%	6.3%	12.0%	14.3%	14.3%	+0.0 pts
Return on capital employed	14.7%	6.4%	5.8%	7.2%	13.8%	16.5%	—	—
Debt / equity	0.3×	0.3×	0.3×	0.3×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	21.3%	18.7%	22.0%	17.9%	1.1%	0.3%	—	—
Interest coverage	98.3×	8.1×	5.0×	4.9×	56.6×	61.4×	—	—
Current ratio	2.0×	1.8×	1.6×	2.6×	4.6×	3.2×	3.2×	+0.0%
Quick ratio	1.7×	1.5×	1.4×	2.4×	3.9×	2.6×	—	—
Cash ratio	0.0×	0.0×	0.0×	0.6×	0.0×	0.1×	0.1×	+0.0%
Asset turnover	0.8×	0.7×	0.6×	0.7×	1.1×	0.9×	—	—
Inventory turnover	7.4×	7.5×	6.7×	7.4×	7.4×	5.7×	—	—
Receivables turnover	2.8×	3.0×	2.7×	2.3×	3.6×	4.4×	—	—
Dividend payout	0.0%	0.0%	14.1%	0.0%	0.0%	0.0%	—	—